Literature DB >> 15919238

Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure.

Giovanni Cioffi1, Luigi Tarantini, Stefania De Feo, Giovanni Pulignano, Donatella Del Sindaco, Carlo Stefenelli, Andrea Di Lenarda, Cristina Opasich.   

Abstract

BACKGROUND AND AIM: Mitral regurgitation (MR) has been demonstrated to be a powerful predictor of adverse outcome in middle-aged patients with chronic heart failure (CHF). In this study, we sought to define the prognostic impact of functional mitral regurgitation in a population of elderly patients with systolic CHF.
METHODS: One hundred seventy-five outpatients aged >70 years with validated CHF and left ventricular ejection fraction <40% underwent clinical and echocardiographic evaluations at baseline. Mitral regurgitation was diagnosed by Color Doppler and quantified in 5 categorical values using a 0-4+ grading system. Outcome measures included 1-year mortality and hospitalization for worsening CHF.
RESULTS: The distribution of patients according to the 5 different degrees of MR detected at baseline was: absent=11%, 1+=31%, 2+=38%, 3+=16%, 4+=4%. The relationship between MR and mortality was direct and approximately linear (r=0.39, p=0.00001). The prevalence of death in the 5 subgroups was 0%, 7%, 15%, 45%, 57%, respectively. Multivariate logistic regression analysis showed that MR was the strongest predictor of death (OR 4.47, 95% CI 1.50-13.0), independently of the presence of diabetes mellitus, older age and larger left ventricular end-diastolic volume. No association was found between MR and hospitalization for worsening CHF (r=0.08, p=0.41).
CONCLUSIONS: This study establishes the direct and independent relationship between MR severity and one-year mortality among elders with systolic CHF. Conversely, MR does not provide useful information regarding the risk of subsequent hospitalization for worsening CHF.

Entities:  

Mesh:

Year:  2005        PMID: 15919238     DOI: 10.1016/j.ejheart.2005.01.016

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  17 in total

1.  Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatase.

Authors:  P Chiarugi; M L Taddei; G Ramponi
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

Review 2.  Ischemic and functional mitral regurgitation in heart failure: natural history and treatment.

Authors:  Mina M Benjamin; Robert L Smith; Paul A Grayburn
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation: A Systematic Review and Meta-analysis.

Authors:  Anna Sannino; Robert L Smith; Gabriele G Schiattarella; Bruno Trimarco; Giovanni Esposito; Paul A Grayburn
Journal:  JAMA Cardiol       Date:  2017-10-01       Impact factor: 14.676

Review 4.  Percutaneous mitral valve interventions: overview of new approaches.

Authors:  Steven L Goldberg; Ted Feldman
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

5.  Beneficial effects of adaptive servo-ventilation therapy on readmission and medical costs in patients with chronic heart failure.

Authors:  Go Hiasa; Hideki Okayama; Saki Hosokawa; Tetsuya Kosaki; Go Kawamura; Tatsuya Shigematsu; Tatsunori Takahashi; Yoshitaka Kawada; Tadakatsu Yamada; Hiroshi Matsuoka; Makoto Saito; Takumi Sumimoto; Yukio Kazatani
Journal:  Heart Vessels       Date:  2018-01-22       Impact factor: 2.037

Review 6.  Prognostic role of transthoracic echocardiography in patients affected by heart failure and reduced ejection fraction.

Authors:  Maria Prastaro; Carmen D'Amore; Stefania Paolillo; Mariangela Losi; Caterina Marciano; Cinzia Perrino; Donatella Ruggiero; Paola Gargiulo; Gianluigi Savarese; Bruno Trimarco; Pasquale Perrone Filardi
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

Review 7.  [Aftercare of patients after MitraClip® implantation].

Authors:  A Schlitt; E Lubos; M Guha; C Hegeler-Molkewehrum; M Sudau; H Schmidt
Journal:  Herz       Date:  2016-06-27       Impact factor: 1.443

8.  Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial.

Authors:  Maryse Palardy; Lynne W Stevenson; Gudaye Tasissa; Michele A Hamilton; Robert C Bourge; Thomas G Disalvo; Uri Elkayam; James A Hill; Sharon C Reimold
Journal:  Circ Heart Fail       Date:  2009-04-14       Impact factor: 8.790

9.  Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial.

Authors:  Janusz Lipiecki; Tomasz Siminiak; Horst Sievert; Jochen Müller-Ehmsen; Hubertus Degen; Justina C Wu; Christian Schandrin; Piotr Kalmucki; Ilona Hofmann; David Reuter; Steven L Goldberg; Michael Haude
Journal:  Open Heart       Date:  2016-07-08

10.  Simultaneous transcatheter treatment of ascending aortic aneurysm with aortic and mitral regurgitation: an in vitro study.

Authors:  Yuxi Zhao; Tao Li; Mingwei Wu; Zhaoxiang Zeng; Minxin Gao; Xianhao Bao; Ziyi Xu; Jian Zhou; Jiaxuan Feng; Rui Feng; Zaiping Jing
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.